CSIMarket
 

Psychemedics Corporation  (PMD)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Psychemedics's

Competitiveness




 

PMD Sales vs. its Competitors Q4 2024



Comparing the current results to its competitors, Psychemedics reported Revenue decrease in the 4 quarter 2024 year on year by -18.8 %, despite the revenue increase by the most of its competitors of 12.13 %, recorded in the same quarter.

List of PMD Competitors

With a net margin of 4.31 % Psychemedics reported lower profitability than its competitors.

More on PMD Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Psychemedics Corporation achieved net profit of $0.19 millions compared to a net loss of $-0.95 millions recorded in the same quarter a year ago.

<<  PMD Stock Performance Comparisons


Psychemedics's Comment on Competition and Industry Peers


The company competes by promoting its patented hair analysis method, which provides higher detection rates and a longer detection window than urinalysis. Its prices are slightly higher than those of urinalysis tests, which may affect volume growth. The company also competes with other hair testing laboratories, distinguishing itself through the results of its proprietary method.



  

Overall company Market Share Q4 2024

Overall company, revenue fell by -18.8 % and company lost market share, to approximately 0.02 %.




<<  More on PMD Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Psychemedics Corporation




Quest Diagnostics Inc
Share Performance



+38.18%
This Year



Quest Diagnostics Inc
Profile

Quest Diagnostics Inc operates as a leading provider of clinical laboratory and diagnostic information services, catering to patients, healthcare professionals, hospitals, and pharmaceutical companies. The company generates revenue through a comprehensive suite of diagnostic testing services, encompassing routine lab tests, advanced molecular diagnostics, and a variety of specialized tests tailored to support clinical decision-making and patient care.

More about Quest Diagnostics Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 26,896.240 mill. $ 11,560.000 mill. $ 1,113.000 mill.


Labcorp Holdings Inc
Share Performance



-1.01%
Over The Past 5 Days



Labcorp Holdings Inc
Profile

Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.

More about Labcorp Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 27,617.306 mill. $ 14,144.200 mill. $ 942.700 mill.


Ispecimen inc
Share Performance



-86.98%
This Year



Ispecimen inc
Profile

iSpecimen Inc's business model revolves around connecting researchers with the biospecimens they need for their scientific and medical studies. They serve as an intermediary platform that links healthcare organizations and biobanks to the research community, providing a streamlined process for sourcing human biosamples and associated data.

More about Ispecimen inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.078 mill. $ 0.466 mill. $ -11.420 mill.


First Choice Healthcare Solutions Inc
Share Performance



+3.75%
Over The Past 5 Days



First Choice Healthcare Solutions Inc
Profile

First Choice Healthcare Solutions, Inc. operates on a business model focused on providing healthcare services to patients.

More about First Choice Healthcare Solutions Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.274 mill. $ - mill. $ -13.372 mill.


Exagen Inc
Share Performance



-0.27%
Over The Past 5 Days



Exagen Inc
Profile

Exagen Inc's business model revolves around providing diagnostic testing solutions in the field of autoimmune diseases.

More about Exagen Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 181.234 mill. $ 71.427 mill. $ 3.702 mill.

3 more competitors available

Sign in to see all competitors

Sources: Psychemedics Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Psychemedics Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.